Voters believe prescription drugs expensive mainly due to Big Pharma greed
Survey results, 31% of voters think that forcing pharmaceutical companies to lower prices will “reduce the number of new and better drugs that those companies are able to create” and 45% Said It Will NOT.
By
A majority of voters think that high prescription drug prices are primarily due to the greed of pharmaceutical companies, according to a new poll.
Only 20% think that high costs are the result of excessive government regulations, and only 17% attribute high costs to research and development, according to a Napolitan News Service poll of 1,000 voters nationwide that was conducted May 14-15.
Most voters, 56%, said the high costs are due to the greed of pharmaceutical companies. The breakdown was 47% of Republicans and 60% of Democrats.
“Just 24% of Republicans and 18% of Democrats say that the costs are due to excessive regulations, and 20% of Republicans and 17% of Democrats say they are primarily due to the high costs of research and development,” said a Napolitan News Service release.
According to the survey results, 31% of voters think that forcing pharmaceutical companies to lower prices will “reduce the number of new and better drugs that those companies are able to create” and 45% said it will not.
The results showed that 47% of Republicans and 43% of Democrats said it would not reduce the number of new and better drugs created.
Most voters, 50% to 38%, said it would be “good for Americans if the government paid for most health care and could therefore decide which drugs would or would not be available,” the press release said.
“A plurality of Republicans (49%) and a majority (52%) of Democrats also say that it would be good for Americans if the government paid for most health care and could decide which drugs were and were not available,” the release said.
*********
(TLB) published this article with permission of John Solomon at Just the News. Click Here to read about the staff at Just the News
Header featured image (edited) credit: CADTM. Emphasis & pictorial content added by (TLB)
••••
••••
Stay tuned…
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
••••
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Leave a Reply